Table 3. Characteristics for patients developing TB during and after IPT in Kenya, 2015–2018.
| Category | Overall n (%) | TB Diagnosis | P-value | |
|---|---|---|---|---|
| During IPT n (%) | Post IPT n (%) | |||
| Age group (yrs) | ||||
| 0–9 | 4 (9.5) | 1(6.2) | 3 (11.5) | 0.5 |
| 10–14 | 1 (2.3) | 0 (0) | 1 (3.8) | |
| 15–19 | 3 (7.1) | 2 (12.5) | 1 (3.8) | |
| 20–25 | 2 (4.7) | 0 (0) | 2 (7.6) | |
| 25+ | 32 (76.1) | 13 (81.2) | 19 (73.0) | |
| Sex | ||||
| Female | 24 (57.1) | 5 (31.2) | 19 (73) | 0.008 |
| Male | 18 (42.8) | 11(68.7) | 7 (26.9) | |
| Viral load before IPT initiation | ||||
| Unsuppressed | 6 (14.2) | 1(6.2) | 5 (19.2) | 0.8 |
| Suppressed | 13 (30.9) | 3 (18.7) | 10 (38.4) | |
| Not Documented | 23 (54.7) | 12 (75) | 11 (42.3) | |
| Viral load after IPT Initiation | ||||
| Unsuppressed | 7 (16.6) | 0 (0) | 7 (26.9) | 0.03 |
| Suppressed | 27 (64.2) | 12 (75) | 15 (57.6) | |
| Not Documented | 8 (19) | 4 (25) | 4 (15.3) | |
| Facility type | ||||
| Faith-based | 13 (30.9) | 4 (25) | 9 (34.6) | 0.07 |
| Public | 26 (61.9) | 9 (56.2) | 17 (65.3) | |
| Private | 3 (7.1) | 3 (18.7) | 0 (0) | |
| Routine screening | ||||
| Yes | 41 (97.6) | 15 (93.7) | 26 (100) | 0.2 |
| No | 1 (2.4) | 1 (6.3) | 0 | |
| Clinic IPT initiated | ||||
| CCC | 39 (92.8) | 13 (81.2) | 26 (100) | 0.02 |
| OPD | 3 (7.2) | 3 (18.8) | 0 | |
TB–tuberculosis; IPT–isoniazid preventive therapy; CCC–comprehensive care clinics; OPD–out-patient department